Bayer Prolactin Receptor Antibody For Male And Female Pattern Hair Loss

poopfeast420

Established Member
My Regimen
Reaction score
188
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?
 

FollicleGuardian

Established Member
My Regimen
Reaction score
732
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?
Amazing find bro!
 

Gegen

Established Member
My Regimen
Reaction score
359
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?
Here's my dopamine rush
so_good.jpg
 

trialAcc

Senior Member
My Regimen
Reaction score
1,531
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?
That's actually a large series-B for a company who's primary indication is hairloss. These guys are not playing around and there must be some serious hype on this antibody behind the scenes.

Seriously, can anyone name a larger funding round for a leading hairloss compound? Most companies are kicking scraps of funding in the single millions if lucky.
 
Last edited:

pegasus2

Senior Member
My Regimen
Reaction score
4,512
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?
Awesome. Wish we knew what soon was.
 

FilthyFrancis

Established Member
My Regimen
Reaction score
481
https://www.asiaone.com/business/ho...nancing-strengthening-capabilities-global?amp

Tl;dr: Hopemed closes $56mm series B round. Will be used to fund HMI-115 phase 2 alopecia studies for US/CN/EU, which will start "soon" (2021 for sure it seems). Again confirmed successful HMI-115 phase 1 in humans.

Ok, between this and Kintor the Chinese are officially not here to f*** around. If they start and finish phase 2 in 2021 and immediately go to phase 3, could we see this drug released in early 2023?

HM's investors from Series A followed in the Series B which is usually a good indicator of the company's performance.

Most of the time, historical investors usually try to flee from the company and cash-out on the next financing rounds
 
Top